ASCIA Anaphylaxis e-training for health professionals 2026
This latest course has been developed by ASCIA to provide accessible, consistent and evidence-based anaphylaxis training for health professionals in Australia and New Zealand, at no charge.
RACGP Accredited
ACRRM Accredited
APC Accredited CPD
Launched: January 2026
ASCIA Anaphylaxis refresher e-training for HPs 2026
This course has been developed to upskill or as interim refresher training. It does not replace the comprehensive ASCIA Anaphylaxis e-training courses for health professionals. It includes approved adrenaline injectors and adrenaline nasal sprays.
Available since July 2026.
ASCIA Food allergy e-training for health professionals 2026
This course has been developed by ASCIA to provide accessible, consistent and evidence-based food allergy training for health professionals in Australia and New Zealand, at no charge.
Launched May 2026.
ASCIA Food Allergy Course for Dietitians
This Food Allergy Course for Dietitians has been developed by ASCIA to provide accessible, consistent and evidence-based training for health professionals in Australia and New Zealand, at no charge.
In order to gain a Certificate of Completion, participants must be a practicing dietitian and attend the face-to-face training component of the course.
Launched: August 2025
ASCIA Allergic rhinitis e-training for health professionals
Launched March 2022.
ASCIA Allergic rhinitis e-training for health professionals 2025
This course has been developed by ASCIA to provide accessible, consistent and evidence-based allergic rhinitis training for health professionals in Australia and New Zealand, at no charge.
Launched: April 2025.
ASCIA Allergen immunotherapy e-training
ASCIA Hereditary Angioedema (HAE)
The Hereditary Angioedema (HAE) course has been developed by the Australasian Society of Clinical Immunology and Allergy (ASCIA), the peak professional body for allergy and clinical immunology in Australia and New Zealand.
ASCIA HAE e-training for health professionals has been developed to complement the other ASCIA e-training courses on this site.
ASCIA Immunoglobulin Replacement Therapy
This training has been developed in conjunction with the National Prescribing Service (NPS) Medicinewise Value in Prescribing (ViP) Immunoglobulin (Ig) Project.
ASCIA Primary immunodeficiency
ASCIA primary immunodeficiency (PID) e-training for health professionals (HP) has been developed by the Australasian Society of Clinical Immunology and Allergy (ASCIA) to provide ready access to reliable PID education for health professionals throughout Australia and New Zealand, at no charge.
ASCIA Infant feeding for food allergy prevention e-training for health professionals 2026
ASCIA infant feeding for food allergy prevention e-training for health professionals has been developed by ASCIA in consultation with the National Allergy Council. This course provides accessible, consistent and evidence-based training for medical practitioners and other health professionals in Australia and New Zealand at no charge.
ASCIA Paediatric atopic dermatitis (eczema) e-training for health professionals 2026
This course has been developed by ASCIA and the National Allergy Strategy to provide accessible, consistent and evidence-based paediatric atopic dermatitis (eczema) training for health professionals in Australia and New Zealand, at no charge.
ASCIA Paediatric atopic dermatitis (eczema) e-training for HPs
This course has been developed by ASCIA and the National Allergy Strategy to provide accessible, consistent and evidence-based paediatric atopic dermatitis (eczema) training for health professionals in Australia and New Zealand, at no charge.
ASCIA Adult Penicillin Allergy Assessment and Management e-training for HPs
This course has been developed by ASCIA to provide training for health professionals in Australia and New Zealand to assess and manage adults lablled with a penicillin allergy. This course is available free of charge.
Launched: September 2026
ASCIA Drug (medication) allergy e-training for HPs
This course has been developed to provide accessible, consistent and evidence-based drug allergy training for health professionals in Australia and New Zealand, at no charge.
Launched: February 2026
